kj103
mAbexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started May 31, 2022 (NCT05274659)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06607016 | Phase 2 | Oct 31, 2024 | Government of China |
| NCT05274659 | Phase 1 | May 31, 2022 | Government of China, New Zealand Clinical Research |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Government of China | Government | 2 | 2 | 2 | 2022 |
| New Zealand Clinical Research | For profit | 1 | 0 | 1 | 2022 |
2 organizations
Page 1 / 1